Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-23 | New | $3,304,000 | $3,304,000 | Debt Only | 06b | SEC link |
| 2025-05-14 | Amended | $2,996,000 | $0 | Debt Only | 06b | SEC link |
| 2025-05-13 | New | $2,996,000 | $2,996,000 | Debt Only | 06b | SEC link |
| 2024-12-23 | New | $7,340,000 | $7,340,000 | Equity Only | 06b | SEC link |
| 2021-08-10 | Amended | $6,898,219 | Unknown | Equity Only | SEC link | |
| 2021-02-18 | New | $437,794 | $437,794 | Equity Only | 06b | SEC link |
| 2021-02-18 | New | $429,585 | $429,585 | Other | 06b | SEC link |
| 2021-02-17 | Amended | $5,055,793 | $64,260 | Equity Only | 06b | SEC link |
| 2020-02-21 | Amended | $4,991,533 | $4,691,531 | Equity Only | 06b | SEC link |
| 2019-07-30 | New | $300,002 | $300,002 | Equity Only | 06b | SEC link |
| 2019-07-30 | Amended | $4,999,906 | $158,703 | Equity Only | 06b | SEC link |
| 2019-05-17 | Amended | $4,841,203 | $49,928 | Equity Only | 06b | SEC link |
| 2019-05-06 | Amended | $4,791,275 | $208,632 | Equity Only | 06b | SEC link |
| 2019-04-18 | Amended | $4,582,643 | $1,784,738 | Equity Only | 06b | SEC link |
| 2019-04-05 | Amended | $2,797,905 | $2,303,782 | Equity Only | 06b | SEC link |
| 2019-03-12 | New | $494,123 | $494,123 | Equity Only | 06b | SEC link |
| 2018-05-31 | Amended | $8,106,688 | $2,122,418 | Equity Only | 06b | SEC link |
| 2018-03-23 | New | $5,984,270 | $5,984,270 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Richard A. Gimigliano | Executive |
| Farrukh Hameed | Director |
| Farnkh Hameed | Director |
| C. Eric Hunter | Director, Executive |
| Jocelyn Hunter | Executive |
| Jay Phillip Morgan | Director |
| J. Knox Morgan | Director |
| Walter L. Robb | Director |
| May Shen | Executive |
| J. Knox Singleton | Director |
| Douglas E. Singleton | Director |
| Douglas E. Stoner | Director |
| Sally Yanchus | Executive |
| Wei Zheng | Director |